Washington, DC (February 11, 2021) -- New research indicates that efforts to improve access to kidney transplantation in recent years have not been effective. The findings appear in an upcoming issue of JASN.
Kidney transplantation is the best treatment option for patients with kidney failure, significantly improving their quality of life and prolonging their survival. Unfortunately, patients can face significant barriers to being evaluated for transplantation and placed on a transplant waiting list. In recent years, studies have identified such barriers and have pointed out disparities faced by certain patient groups. Moreover, numerous policies, research studies, and interventions have been designed to address these shortcomings and improve access to transplantation.
To examine the effects of such efforts, Jesse Schold, PhD, MStat, MEd (Cleveland Clinic) and his colleagues analyzed information on 1,309,998 adults with kidney failure listed in the United States Renal Data System from 1997 to 2016. The researchers found no overall improvement in rates of wait list placement and transplantation over the 2 decades, and they found consistently low rates among vulnerable populations, such as those in lower income communities.
"These findings suggest that the cumulative efforts to improve access to transplantation have had minimal effect in the overall population and more effective strategies are needed," said Dr. Schold. "In addition, disparities in access to transplantation are striking and suggest that many factors beyond clinical risks and viability for the procedure impact patients' ability to receive a transplant."
Dr. Schold stressed that more effective and proactive strategies are needed to improve access to transplantation. "These may include systematic capture of patients referred and evaluated for transplantation, automated referral of patients for transplantation based on eligibility criteria, and incentive policies such as those initiated by the Executive Order for Advancing American Kidney Health."
Study co-authors include Sumit Mohan, MD, MPH, Anne Huml, MD, Laura D. Buccini, DrPH, MS, John R. Sedor, MD, PhD, Josh J. Augustine, MD, and Emilio D. Poggio, MD.
Disclosures: The authors reported no relevant financial disclosures.
The article, titled "Failure to Advance Access to Kidney Transplantation over Two Decades in the United States," will appear online at http://jasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit http://www.